Last Name

Jeremy Carlos Burns

TitlePre-Doctoral Trainee
InstitutionBoston University School of Medicine, Division of Graduate Medical Sciences
DepartmentPharmacology & Experimental Therapeutics
ORCID ORCID Icon0000-0003-3853-0237
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Yu C, Burns JC, Robinson WH, Utz PJ, Ho PP, Steinman L, Frey AB. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model. J Diabetes Res. 2016; 2016:9083103. PMID: 27069933.
    View in: PubMed
  2. Vazquez-Cintron EJ, Monu NR, Burns JC, Blum R, Chen G, Lopez P, Ma J, Radoja S, Frey AB. Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells. PLoS One. 2012; 7(5):e36101. PMID: 22567129.
    View in: PubMed
  3. Burns JC, Corbo E, Degen J, Gohil M, Anterasian C, Schraven B, Koretzky GA, Kliche S, Jordan MS. The SLP-76 Src homology 2 domain is required for T cell development and activation. J Immunol. 2011 Nov 1; 187(9):4459-66. PMID: 21949020.
    View in: PubMed
  4. Smith-Garvin JE, Burns JC, Gohil M, Zou T, Kim JS, Maltzman JS, Wherry EJ, Koretzky GA, Jordan MS. T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool. Blood. 2010 Dec 16; 116(25):5548-59. PMID: 20847203.
    View in: PubMed
  5. Jordan MS, Smith JE, Burns JC, Austin JE, Nichols KE, Aschenbrenner AC, Koretzky GA. Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity. 2008 Mar; 28(3):359-69. PMID: 18342008.
    View in: PubMed
Jeremy's Networks
Click the "See All" links for more information and interactive visualizations!
Similar BU People
Same Department